Cherries are the single most-studied food for gout, and the evidence from the landmark 2012 case-crossover study from Boston University School of Medicine is unusually positive for a dietary intervention. The study found that cherry intake over a two-day period was associated with a 35% lower risk of recurrent gout attacks — an effect size comparable to some pharmacological interventions. But like all nutrition research, the details of the study matter as much as the headline number. Here is what the study actually measured, how cherries work at the molecular level, and what that means for incorporating cherries into a gout management plan.
The Study Design: Why This Research Is Stronger Than Most Nutrition Studies
Nutrition research is notoriously difficult because it is almost impossible to run a randomized controlled trial — you cannot randomly assign people to eat cherries or not eat cherries for years and track gout outcomes. The Boston University team used a case-crossover design, which is one of the strongest observational study designs available.
In a case-crossover study, each participant serves as their own control. The researchers compared each participant's cherry intake during "hazard periods" — the 48 hours immediately before a gout attack — to their intake during randomly selected "control periods" when they were attack-free. Because each person is compared to themselves, the design automatically controls for all stable individual differences: genetics, baseline uric acid levels, medication use, diet, body weight, and lifestyle. What varies is only the cherry intake. This makes the results far more reliable than a traditional cohort study where cherry-eaters and non-cherry-eaters might differ in dozens of other ways.
The study tracked 633 participants with confirmed gout (mean age 54, 78% male) over one year through online surveys. Participants reported 1,247 gout attacks during the study period. The cherry consumption data was collected through detailed dietary questionnaires covering the 48-hour windows before attacks and before randomly assigned control dates.
How Many Cherries? The Dose-Response Curve
The study did not just find that cherries help — it found a dose-response relationship, which is one of the hallmarks of a genuine causal effect. The researchers defined one serving as 10-12 cherries (roughly half a cup, or about 80-100 grams). The 35% risk reduction was observed with one to two servings per 48-hour period. Three servings (30-36 cherries, or about 1.5 cups) provided slightly more protection — approximately 40% — but the benefit plateaued after three servings. More than three servings did not provide additional protection, suggesting a ceiling effect.
This is a practical finding. A dose of 10-36 cherries over two days is affordable and achievable — a small bowl of fresh cherries or a serving of frozen cherries from the grocery store. There is no need to consume cherries by the pound. The optimal range appears to be 1-3 servings (10-36 cherries) over 48 hours, consumed as fresh or frozen fruit.
Tart vs Sweet: The Anthocyanin Difference
Not all cherries are equal for gout. The study found that tart cherries (Prunus cerasus, Montmorency variety) showed a stronger protective effect than sweet cherries (Prunus avium, Bing variety). The reason lies in anthocyanin concentration. Tart cherries contain 2-3 times more anthocyanins than sweet cherries — typically 30-60 mg per 100g versus 10-20 mg per 100g for sweet varieties. Anthocyanins are the red-purple pigments that give cherries their color, and they are the bioactive compounds responsible for the anti-gout effect.
Anthocyanins work through two complementary mechanisms relevant to gout. First, they inhibit xanthine oxidase — the same enzyme targeted by allopurinol and febuxostat — modestly reducing uric acid production. Second, they suppress NLRP3 inflammasome activation, the inflammatory pathway that triggers the intense pain, swelling, and redness of an acute gout flare. This dual mechanism — uric acid lowering plus anti-inflammatory — explains why cherries reduce attack frequency without necessarily normalizing uric acid levels.
Fresh, Frozen, Juice, or Extract?
The study examined multiple forms of cherry intake and found benefits across the board, but with important distinctions. Fresh cherries showed the strongest and most consistent effect (OR 0.65). Frozen cherries were nearly equivalent — freezing preserves anthocyanins well. Cherry extract (concentrated anthocyanin supplement) showed an even stronger signal (OR 0.55), but with a wider confidence interval due to smaller sample size.
Cherry juice is the most complicated case. While the extract data suggests concentrated anthocyanins are effective, commercial cherry juices often contain added sugar, high-fructose corn syrup, or are blended with apple or grape juice — all of which introduce fructose, which independently raises uric acid through hepatic ATP depletion. This fructose load can partially or completely offset the anthocyanin benefit. If choosing cherry juice, it must be unsweetened, 100% tart cherry juice, and limited to a small serving of 4-6 ounces (120-180 ml) — roughly the equivalent of one serving of whole cherries.
GoutFoodGuide data shows cherries contain only 1.4g fructose per 100g (USDA SR28), making them among the lowest-fructose fruits available. This is an important secondary benefit — unlike mangoes (5-7g fructose/100g), grapes (7-8g), or dried fruits (10-30g), cherries deliver their anthocyanin benefit without a significant fructose penalty.
The Allopurinol Interaction: Why This Matters
One of the study's most striking findings was the interaction between cherries and allopurinol. When participants used both cherries and allopurinol, the risk reduction was approximately 75% — dramatically larger than either intervention alone. This suggests a synergistic effect: allopurinol reduces uric acid production through xanthine oxidase inhibition, while cherries add a second xanthine oxidase inhibition pathway (via anthocyanins) plus anti-inflammatory NLRP3 suppression.
This does not mean cherries replace medication — allopurinol's uric acid-lowering effect is far more potent than cherries. But it does mean that cherries may be a useful dietary adjunct for patients already on urate-lowering therapy, potentially improving outcomes beyond medication alone. Always discuss dietary changes with your prescribing physician, particularly if you are on urate-lowering therapy where dose adjustments require monitoring.
The Practical Takeaway
Cherries are one of the very few foods with both epidemiological evidence (the 2012 study) and a plausible biological mechanism (anthocyanin-mediated xanthine oxidase inhibition and NLRP3 suppression) for gout benefit. The optimal dose appears to be 1-3 servings (10-36 cherries, or about 80-300g) over two days, with tart cherries providing the strongest effect. Fresh or frozen cherries are preferred over juice due to the fructose concentration issue. At roughly $3-5 per pound for fresh tart cherries in season (and less for frozen), this is one of the most cost-effective dietary additions for gout management — and carries essentially zero risk of side effects.
Cherries are not a substitute for urate-lowering therapy or comprehensive dietary management. But as an evidence-backed dietary adjunct, they have stronger research support than almost any other single food studied for gout — and they taste good. That combination is rare in medical nutrition.
Reviewed against USDA+ODS-NIH PURINE DATABASE Release 2 (March 2025). Reference: Zhang Y et al. Arthritis Rheum 2012;64(12):4004-4011. DOI: 10.1002/art.34677.